KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,909 | +632.7% | 10,807 | +1840.2% | 0.00% | – |
| Q1 2021 | $15,000 | -59.5% | 557 | -75.5% | 0.00% | – |
| Q4 2020 | $37,000 | +311.1% | 2,269 | +259.6% | 0.00% | – |
| Q3 2020 | $9,000 | -30.8% | 631 | -41.6% | 0.00% | – |
| Q2 2020 | $13,000 | -53.6% | 1,081 | -31.5% | 0.00% | – |
| Q4 2019 | $28,000 | +133.3% | 1,579 | +54.5% | 0.00% | – |
| Q3 2019 | $12,000 | -45.5% | 1,022 | +4.9% | 0.00% | – |
| Q2 2019 | $22,000 | -86.7% | 974 | -83.3% | 0.00% | – |
| Q1 2019 | $166,000 | +84.4% | 5,824 | +28.5% | 0.00% | – |
| Q4 2018 | $90,000 | – | 4,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |